nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitotane—SHBG—osteoporosis	0.322	1	CbGaD
Mitotane—Cloperastine—Raloxifene—osteoporosis	0.199	1	CrCrCtD
Mitotane—SHBG—Estropipate—osteoporosis	0.131	0.369	CbGbCtD
Mitotane—CYP11A1—Cholecalciferol—osteoporosis	0.0847	0.239	CbGbCtD
Mitotane—SHBG—Ethinyl Estradiol—osteoporosis	0.0842	0.238	CbGbCtD
Mitotane—SHBG—Estradiol—osteoporosis	0.0542	0.153	CbGbCtD
Mitotane—FDX1—Endogenous sterols—CYP27A1—osteoporosis	0.00375	0.0899	CbGpPWpGaD
Mitotane—FDX1—Endogenous sterols—CYP19A1—osteoporosis	0.00197	0.0472	CbGpPWpGaD
Mitotane—FDX1—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.00174	0.0417	CbGpPWpGaD
Mitotane—FDX1—Metabolism of steroid hormones and vitamin D—CYP19A1—osteoporosis	0.00147	0.0354	CbGpPWpGaD
Mitotane—FDX1—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.00141	0.0338	CbGpPWpGaD
Mitotane—CYP11B1—Endogenous sterols—CYP27A1—osteoporosis	0.00134	0.032	CbGpPWpGaD
Mitotane—FDX1—Endogenous sterols—POMC—osteoporosis	0.00118	0.0284	CbGpPWpGaD
Mitotane—CYP11A1—Endogenous sterols—CYP27A1—osteoporosis	0.00114	0.0274	CbGpPWpGaD
Mitotane—CYP11A1—Prostaglandin Synthesis and Regulation—ANXA2—osteoporosis	0.00106	0.0253	CbGpPWpGaD
Mitotane—CYP11B1—Glucocorticoid biosynthesis—POMC—osteoporosis	0.000981	0.0235	CbGpPWpGaD
Mitotane—FDX1—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000914	0.0219	CbGpPWpGaD
Mitotane—FDX1—Metabolism of steroid hormones and vitamin D—POMC—osteoporosis	0.000886	0.0213	CbGpPWpGaD
Mitotane—FDX1—Biological oxidations—CYP27A1—osteoporosis	0.000749	0.018	CbGpPWpGaD
Mitotane—FDX1—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000741	0.0178	CbGpPWpGaD
Mitotane—CYP11B1—Endogenous sterols—CYP19A1—osteoporosis	0.000701	0.0168	CbGpPWpGaD
Mitotane—CYP11B1—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.00062	0.0149	CbGpPWpGaD
Mitotane—CYP11B1—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000612	0.0147	CbGpPWpGaD
Mitotane—CYP11A1—Endogenous sterols—CYP19A1—osteoporosis	0.0006	0.0144	CbGpPWpGaD
Mitotane—FDX1—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000549	0.0132	CbGpPWpGaD
Mitotane—CYP11A1—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.00053	0.0127	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of steroid hormones and vitamin D—CYP19A1—osteoporosis	0.000525	0.0126	CbGpPWpGaD
Mitotane—CYP11A1—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000523	0.0126	CbGpPWpGaD
Mitotane—CYP11B1—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000503	0.0121	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000501	0.012	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000475	0.0114	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of steroid hormones and vitamin D—CYP19A1—osteoporosis	0.00045	0.0108	CbGpPWpGaD
Mitotane—FDX1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000445	0.0107	CbGpPWpGaD
Mitotane—CYP11A1—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.00043	0.0103	CbGpPWpGaD
Mitotane—CYP11B1—Endogenous sterols—POMC—osteoporosis	0.000422	0.0101	CbGpPWpGaD
Mitotane—Econazole—CYP19A1—osteoporosis	0.000414	1	CrCbGaD
Mitotane—FDX1—Biological oxidations—CYP19A1—osteoporosis	0.000394	0.00944	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000369	0.00886	CbGpPWpGaD
Mitotane—CYP11A1—Endogenous sterols—POMC—osteoporosis	0.000361	0.00865	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.00036	0.00864	CbGpPWpGaD
Mitotane—CYP11B1—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000326	0.00781	CbGpPWpGaD
Mitotane—CYP11B1—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000321	0.00771	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of steroid hormones and vitamin D—POMC—osteoporosis	0.000316	0.00758	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000288	0.0069	CbGpPWpGaD
Mitotane—CYP11A1—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000279	0.00668	CbGpPWpGaD
Mitotane—CYP11A1—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000275	0.0066	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of steroid hormones and vitamin D—POMC—osteoporosis	0.00027	0.00648	CbGpPWpGaD
Mitotane—CYP11B1—Biological oxidations—CYP27A1—osteoporosis	0.000267	0.0064	CbGpPWpGaD
Mitotane—CYP11B1—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000264	0.00633	CbGpPWpGaD
Mitotane—CYP11B1—Metapathway biotransformation—CYP27A1—osteoporosis	0.000263	0.00632	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000245	0.00587	CbGpPWpGaD
Mitotane—FDX1—Biological oxidations—POMC—osteoporosis	0.000237	0.00568	CbGpPWpGaD
Mitotane—CYP11A1—Biological oxidations—CYP27A1—osteoporosis	0.000228	0.00548	CbGpPWpGaD
Mitotane—CYP11A1—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000226	0.00542	CbGpPWpGaD
Mitotane—CYP11A1—Metapathway biotransformation—CYP27A1—osteoporosis	0.000225	0.0054	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PKM—osteoporosis	0.000223	0.00535	CbGpPWpGaD
Mitotane—FDX1—Metabolism—FDPS—osteoporosis	0.000223	0.00535	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PGLS—osteoporosis	0.000212	0.00507	CbGpPWpGaD
Mitotane—FDX1—Metabolism—GPD2—osteoporosis	0.000212	0.00507	CbGpPWpGaD
Mitotane—CYP11B1—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000196	0.0047	CbGpPWpGaD
Mitotane—FDX1—Metabolism—ATIC—osteoporosis	0.000193	0.00464	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PNP—osteoporosis	0.000193	0.00464	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000179	0.00428	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000169	0.00406	CbGpPWpGaD
Mitotane—CYP11A1—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000167	0.00402	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CA2—osteoporosis	0.000165	0.00395	CbGpPWpGaD
Mitotane—FDX1—Metabolism—OXCT1—osteoporosis	0.000165	0.00395	CbGpPWpGaD
Mitotane—FDX1—Metabolism—MGLL—osteoporosis	0.00016	0.00385	CbGpPWpGaD
Mitotane—CYP11B1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000159	0.00381	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000153	0.00366	CbGpPWpGaD
Mitotane—Skin disorder—Calcitriol—osteoporosis	0.000153	0.00184	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	0.000151	0.00363	CbGpPWpGaD
Mitotane—Eye disorder—Zoledronate—osteoporosis	0.000151	0.00182	CcSEcCtD
Mitotane—Dysgeusia—Pamidronate—osteoporosis	0.000151	0.00182	CcSEcCtD
Mitotane—Paraesthesia—Estropipate—osteoporosis	0.00015	0.00181	CcSEcCtD
Mitotane—Flushing—Zoledronate—osteoporosis	0.00015	0.00181	CcSEcCtD
Mitotane—Visual impairment—Conjugated Estrogens—osteoporosis	0.00015	0.00181	CcSEcCtD
Mitotane—Anaemia—Risedronate—osteoporosis	0.00015	0.0018	CcSEcCtD
Mitotane—Anorexia—Calcitriol—osteoporosis	0.00015	0.0018	CcSEcCtD
Mitotane—Somnolence—Estropipate—osteoporosis	0.000149	0.00179	CcSEcCtD
Mitotane—Dyspepsia—Estropipate—osteoporosis	0.000147	0.00177	CcSEcCtD
Mitotane—Angiopathy—Zoledronate—osteoporosis	0.000147	0.00177	CcSEcCtD
Mitotane—Vertigo—Risedronate—osteoporosis	0.000146	0.00175	CcSEcCtD
Mitotane—Eye disorder—Conjugated Estrogens—osteoporosis	0.000145	0.00175	CcSEcCtD
Mitotane—Dyspepsia—Alendronate—osteoporosis	0.000145	0.00175	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000145	0.00347	CbGpPWpGaD
Mitotane—Gastrointestinal disorder—Estropipate—osteoporosis	0.000144	0.00174	CcSEcCtD
Mitotane—Paraesthesia—Ibandronate—osteoporosis	0.000144	0.00174	CcSEcCtD
Mitotane—Pain—Estropipate—osteoporosis	0.000143	0.00172	CcSEcCtD
Mitotane—Dyspepsia—Raloxifene—osteoporosis	0.000143	0.00172	CcSEcCtD
Mitotane—Hypersensitivity—Etidronic acid—osteoporosis	0.000142	0.00172	CcSEcCtD
Mitotane—Anaemia—Pamidronate—osteoporosis	0.000142	0.00171	CcSEcCtD
Mitotane—Mental disorder—Zoledronate—osteoporosis	0.000142	0.00171	CcSEcCtD
Mitotane—Dyspepsia—Ibandronate—osteoporosis	0.000141	0.0017	CcSEcCtD
Mitotane—Angiopathy—Conjugated Estrogens—osteoporosis	0.000141	0.0017	CcSEcCtD
Mitotane—Pain—Alendronate—osteoporosis	0.000141	0.0017	CcSEcCtD
Mitotane—Malnutrition—Zoledronate—osteoporosis	0.000141	0.00169	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.00014	0.00169	CcSEcCtD
Mitotane—CYP11B1—Biological oxidations—CYP19A1—osteoporosis	0.00014	0.00336	CbGpPWpGaD
Mitotane—Gastrointestinal disorder—Raloxifene—osteoporosis	0.00014	0.00169	CcSEcCtD
Mitotane—Hypertension—Risedronate—osteoporosis	0.00014	0.00169	CcSEcCtD
Mitotane—Somnolence—Calcitriol—osteoporosis	0.00014	0.00168	CcSEcCtD
Mitotane—Decreased appetite—Ibandronate—osteoporosis	0.000139	0.00168	CcSEcCtD
Mitotane—CYP11B1—Corticotropin-releasing hormone—POMC—osteoporosis	0.000139	0.00334	CbGpPWpGaD
Mitotane—Infestation NOS—Estradiol—osteoporosis	0.000139	0.00167	CcSEcCtD
Mitotane—Infestation—Estradiol—osteoporosis	0.000139	0.00167	CcSEcCtD
Mitotane—Pain—Raloxifene—osteoporosis	0.000139	0.00167	CcSEcCtD
Mitotane—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000138	0.00167	CcSEcCtD
Mitotane—CYP11B1—Metapathway biotransformation—CYP19A1—osteoporosis	0.000138	0.00332	CbGpPWpGaD
Mitotane—Dysgeusia—Zoledronate—osteoporosis	0.000138	0.00166	CcSEcCtD
Mitotane—Pain—Ibandronate—osteoporosis	0.000137	0.00165	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000137	0.00165	CcSEcCtD
Mitotane—Decreased appetite—Calcitriol—osteoporosis	0.000137	0.00164	CcSEcCtD
Mitotane—FDX1—Metabolism—IDH2—osteoporosis	0.000136	0.00327	CbGpPWpGaD
Mitotane—Mental disorder—Conjugated Estrogens—osteoporosis	0.000136	0.00164	CcSEcCtD
Mitotane—Feeling abnormal—Alendronate—osteoporosis	0.000136	0.00164	CcSEcCtD
Mitotane—CYP11A1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000136	0.00326	CbGpPWpGaD
Mitotane—Malnutrition—Conjugated Estrogens—osteoporosis	0.000135	0.00163	CcSEcCtD
Mitotane—Infection—Ethinyl Estradiol—osteoporosis	0.000135	0.00162	CcSEcCtD
Mitotane—Pain—Calcitriol—osteoporosis	0.000134	0.00162	CcSEcCtD
Mitotane—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000133	0.0016	CcSEcCtD
Mitotane—Hypertension—Pamidronate—osteoporosis	0.000133	0.0016	CcSEcCtD
Mitotane—Dysgeusia—Conjugated Estrogens—osteoporosis	0.000133	0.0016	CcSEcCtD
Mitotane—Vision blurred—Zoledronate—osteoporosis	0.000133	0.0016	CcSEcCtD
Mitotane—Diarrhoea—Etidronic acid—osteoporosis	0.000132	0.00159	CcSEcCtD
Mitotane—Haematuria—Estradiol—osteoporosis	0.000132	0.00159	CcSEcCtD
Mitotane—Body temperature increased—Estropipate—osteoporosis	0.000132	0.00159	CcSEcCtD
Mitotane—Feeling abnormal—Ibandronate—osteoporosis	0.000132	0.00159	CcSEcCtD
Mitotane—Tremor—Zoledronate—osteoporosis	0.000132	0.00159	CcSEcCtD
Mitotane—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000132	0.00159	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000132	0.00316	CbGpPWpGaD
Mitotane—Infection—Risedronate—osteoporosis	0.000131	0.00158	CcSEcCtD
Mitotane—Hepatobiliary disease—Estradiol—osteoporosis	0.000131	0.00158	CcSEcCtD
Mitotane—Body temperature increased—Alendronate—osteoporosis	0.00013	0.00157	CcSEcCtD
Mitotane—Shock—Risedronate—osteoporosis	0.00013	0.00157	CcSEcCtD
Mitotane—Anaemia—Zoledronate—osteoporosis	0.00013	0.00157	CcSEcCtD
Mitotane—Nervous system disorder—Risedronate—osteoporosis	0.00013	0.00156	CcSEcCtD
Mitotane—Skin disorder—Risedronate—osteoporosis	0.000128	0.00155	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000128	0.00308	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CYP27A1—osteoporosis	0.000128	0.00307	CbGpPWpGaD
Mitotane—Body temperature increased—Raloxifene—osteoporosis	0.000128	0.00154	CcSEcCtD
Mitotane—Vision blurred—Conjugated Estrogens—osteoporosis	0.000128	0.00154	CcSEcCtD
Mitotane—Body temperature increased—Ibandronate—osteoporosis	0.000127	0.00153	CcSEcCtD
Mitotane—Confusional state—Pamidronate—osteoporosis	0.000127	0.00153	CcSEcCtD
Mitotane—Vertigo—Zoledronate—osteoporosis	0.000126	0.00152	CcSEcCtD
Mitotane—Infection—Pamidronate—osteoporosis	0.000125	0.0015	CcSEcCtD
Mitotane—FDX1—Metabolism—ACP5—osteoporosis	0.000125	0.00299	CbGpPWpGaD
Mitotane—Hepatitis—Estradiol—osteoporosis	0.000125	0.0015	CcSEcCtD
Mitotane—Body temperature increased—Calcitriol—osteoporosis	0.000124	0.0015	CcSEcCtD
Mitotane—Shock—Pamidronate—osteoporosis	0.000124	0.00149	CcSEcCtD
Mitotane—Hypersensitivity—Estropipate—osteoporosis	0.000123	0.00149	CcSEcCtD
Mitotane—Nervous system disorder—Pamidronate—osteoporosis	0.000123	0.00149	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	0.000123	0.00295	CbGpPWpGaD
Mitotane—Thrombocytopenia—Pamidronate—osteoporosis	0.000123	0.00148	CcSEcCtD
Mitotane—Urinary tract disorder—Estradiol—osteoporosis	0.000123	0.00148	CcSEcCtD
Mitotane—Vomiting—Etidronic acid—osteoporosis	0.000123	0.00148	CcSEcCtD
Mitotane—Connective tissue disorder—Estradiol—osteoporosis	0.000122	0.00147	CcSEcCtD
Mitotane—Urethral disorder—Estradiol—osteoporosis	0.000122	0.00147	CcSEcCtD
Mitotane—Rash—Etidronic acid—osteoporosis	0.000122	0.00147	CcSEcCtD
Mitotane—Dermatitis—Etidronic acid—osteoporosis	0.000122	0.00147	CcSEcCtD
Mitotane—Vertigo—Conjugated Estrogens—osteoporosis	0.000122	0.00147	CcSEcCtD
Mitotane—Hypertension—Zoledronate—osteoporosis	0.000121	0.00146	CcSEcCtD
Mitotane—Hypersensitivity—Alendronate—osteoporosis	0.000121	0.00146	CcSEcCtD
Mitotane—Headache—Etidronic acid—osteoporosis	0.000121	0.00146	CcSEcCtD
Mitotane—Asthenia—Estropipate—osteoporosis	0.00012	0.00145	CcSEcCtD
Mitotane—Visual impairment—Estradiol—osteoporosis	0.00012	0.00145	CcSEcCtD
Mitotane—CYP11A1—Biological oxidations—CYP19A1—osteoporosis	0.00012	0.00288	CbGpPWpGaD
Mitotane—Anorexia—Pamidronate—osteoporosis	0.00012	0.00144	CcSEcCtD
Mitotane—CYP11A1—Corticotropin-releasing hormone—POMC—osteoporosis	0.000119	0.00285	CbGpPWpGaD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000119	0.00143	CcSEcCtD
Mitotane—Paraesthesia—Risedronate—osteoporosis	0.000119	0.00143	CcSEcCtD
Mitotane—CYP11A1—Metapathway biotransformation—CYP19A1—osteoporosis	0.000118	0.00284	CbGpPWpGaD
Mitotane—Asthenia—Alendronate—osteoporosis	0.000118	0.00142	CcSEcCtD
Mitotane—Hypersensitivity—Ibandronate—osteoporosis	0.000118	0.00142	CcSEcCtD
Mitotane—Hypotension—Pamidronate—osteoporosis	0.000117	0.00142	CcSEcCtD
Mitotane—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000117	0.00141	CcSEcCtD
Mitotane—Dyspepsia—Risedronate—osteoporosis	0.000116	0.0014	CcSEcCtD
Mitotane—Eye disorder—Estradiol—osteoporosis	0.000116	0.0014	CcSEcCtD
Mitotane—FDX1—Metabolism—TPI1—osteoporosis	0.000116	0.00278	CbGpPWpGaD
Mitotane—Confusional state—Zoledronate—osteoporosis	0.000116	0.00139	CcSEcCtD
Mitotane—Hypersensitivity—Calcitriol—osteoporosis	0.000116	0.00139	CcSEcCtD
Mitotane—Flushing—Estradiol—osteoporosis	0.000116	0.00139	CcSEcCtD
Mitotane—Asthenia—Ibandronate—osteoporosis	0.000115	0.00139	CcSEcCtD
Mitotane—Nausea—Etidronic acid—osteoporosis	0.000115	0.00138	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000115	0.00138	CcSEcCtD
Mitotane—Diarrhoea—Estropipate—osteoporosis	0.000114	0.00138	CcSEcCtD
Mitotane—Gastrointestinal disorder—Risedronate—osteoporosis	0.000114	0.00138	CcSEcCtD
Mitotane—Infection—Zoledronate—osteoporosis	0.000114	0.00137	CcSEcCtD
Mitotane—Pain—Risedronate—osteoporosis	0.000113	0.00136	CcSEcCtD
Mitotane—Angiopathy—Estradiol—osteoporosis	0.000113	0.00136	CcSEcCtD
Mitotane—Shock—Zoledronate—osteoporosis	0.000113	0.00136	CcSEcCtD
Mitotane—Paraesthesia—Pamidronate—osteoporosis	0.000113	0.00136	CcSEcCtD
Mitotane—Diarrhoea—Alendronate—osteoporosis	0.000113	0.00136	CcSEcCtD
Mitotane—Asthenia—Calcitriol—osteoporosis	0.000113	0.00136	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000113	0.0027	CbGpPWpGaD
Mitotane—Nervous system disorder—Zoledronate—osteoporosis	0.000113	0.00136	CcSEcCtD
Mitotane—Thrombocytopenia—Zoledronate—osteoporosis	0.000112	0.00135	CcSEcCtD
Mitotane—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000112	0.00135	CcSEcCtD
Mitotane—Somnolence—Pamidronate—osteoporosis	0.000112	0.00135	CcSEcCtD
Mitotane—Skin disorder—Zoledronate—osteoporosis	0.000112	0.00134	CcSEcCtD
Mitotane—Diarrhoea—Raloxifene—osteoporosis	0.000111	0.00134	CcSEcCtD
Mitotane—Dyspepsia—Pamidronate—osteoporosis	0.000111	0.00133	CcSEcCtD
Mitotane—Dizziness—Estropipate—osteoporosis	0.000111	0.00133	CcSEcCtD
Mitotane—Infection—Conjugated Estrogens—osteoporosis	0.00011	0.00132	CcSEcCtD
Mitotane—Diarrhoea—Ibandronate—osteoporosis	0.00011	0.00132	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.00011	0.00263	CbGpPWpGaD
Mitotane—Anorexia—Zoledronate—osteoporosis	0.000109	0.00132	CcSEcCtD
Mitotane—Decreased appetite—Pamidronate—osteoporosis	0.000109	0.00132	CcSEcCtD
Mitotane—Mental disorder—Estradiol—osteoporosis	0.000109	0.00131	CcSEcCtD
Mitotane—FDX1—Metabolism—P4HB—osteoporosis	0.000109	0.00261	CbGpPWpGaD
Mitotane—Dizziness—Alendronate—osteoporosis	0.000109	0.00131	CcSEcCtD
Mitotane—Shock—Conjugated Estrogens—osteoporosis	0.000109	0.00131	CcSEcCtD
Mitotane—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000108	0.00131	CcSEcCtD
Mitotane—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000108	0.00131	CcSEcCtD
Mitotane—Malnutrition—Estradiol—osteoporosis	0.000108	0.00131	CcSEcCtD
Mitotane—Pain—Pamidronate—osteoporosis	0.000107	0.00129	CcSEcCtD
Mitotane—Diarrhoea—Calcitriol—osteoporosis	0.000107	0.00129	CcSEcCtD
Mitotane—Skin disorder—Conjugated Estrogens—osteoporosis	0.000107	0.00129	CcSEcCtD
Mitotane—Hypotension—Zoledronate—osteoporosis	0.000107	0.00129	CcSEcCtD
Mitotane—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000107	0.00129	CcSEcCtD
Mitotane—Dizziness—Raloxifene—osteoporosis	0.000107	0.00129	CcSEcCtD
Mitotane—FDX1—Metabolism—GAPDH—osteoporosis	0.000107	0.00257	CbGpPWpGaD
Mitotane—Vomiting—Estropipate—osteoporosis	0.000106	0.00128	CcSEcCtD
Mitotane—Dysgeusia—Estradiol—osteoporosis	0.000106	0.00128	CcSEcCtD
Mitotane—Dizziness—Ibandronate—osteoporosis	0.000106	0.00128	CcSEcCtD
Mitotane—Rash—Estropipate—osteoporosis	0.000105	0.00127	CcSEcCtD
Mitotane—Dermatitis—Estropipate—osteoporosis	0.000105	0.00127	CcSEcCtD
Mitotane—Anorexia—Conjugated Estrogens—osteoporosis	0.000105	0.00127	CcSEcCtD
Mitotane—Headache—Estropipate—osteoporosis	0.000105	0.00126	CcSEcCtD
Mitotane—Vomiting—Alendronate—osteoporosis	0.000105	0.00126	CcSEcCtD
Mitotane—Body temperature increased—Risedronate—osteoporosis	0.000105	0.00126	CcSEcCtD
Mitotane—FDX1—Metabolism—RAP1A—osteoporosis	0.000104	0.0025	CbGpPWpGaD
Mitotane—Rash—Alendronate—osteoporosis	0.000104	0.00125	CcSEcCtD
Mitotane—Dermatitis—Alendronate—osteoporosis	0.000104	0.00125	CcSEcCtD
Mitotane—Feeling abnormal—Pamidronate—osteoporosis	0.000104	0.00125	CcSEcCtD
Mitotane—Hypotension—Conjugated Estrogens—osteoporosis	0.000103	0.00124	CcSEcCtD
Mitotane—Headache—Alendronate—osteoporosis	0.000103	0.00124	CcSEcCtD
Mitotane—Paraesthesia—Zoledronate—osteoporosis	0.000103	0.00124	CcSEcCtD
Mitotane—Vomiting—Raloxifene—osteoporosis	0.000103	0.00124	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000103	0.00246	CbGpPWpGaD
Mitotane—Rash—Raloxifene—osteoporosis	0.000102	0.00123	CcSEcCtD
Mitotane—Dermatitis—Raloxifene—osteoporosis	0.000102	0.00123	CcSEcCtD
Mitotane—Somnolence—Zoledronate—osteoporosis	0.000102	0.00123	CcSEcCtD
Mitotane—Vomiting—Ibandronate—osteoporosis	0.000102	0.00123	CcSEcCtD
Mitotane—Tremor—Estradiol—osteoporosis	0.000102	0.00122	CcSEcCtD
Mitotane—Headache—Raloxifene—osteoporosis	0.000102	0.00122	CcSEcCtD
Mitotane—Rash—Ibandronate—osteoporosis	0.000101	0.00122	CcSEcCtD
Mitotane—Dermatitis—Ibandronate—osteoporosis	0.000101	0.00122	CcSEcCtD
Mitotane—Dyspepsia—Zoledronate—osteoporosis	0.000101	0.00122	CcSEcCtD
Mitotane—Headache—Ibandronate—osteoporosis	0.0001	0.00121	CcSEcCtD
Mitotane—Hypersensitivity—Ethinyl Estradiol—osteoporosis	9.99e-05	0.0012	CcSEcCtD
Mitotane—Vomiting—Calcitriol—osteoporosis	9.98e-05	0.0012	CcSEcCtD
Mitotane—Decreased appetite—Zoledronate—osteoporosis	9.98e-05	0.0012	CcSEcCtD
Mitotane—Nausea—Estropipate—osteoporosis	9.94e-05	0.0012	CcSEcCtD
Mitotane—Body temperature increased—Pamidronate—osteoporosis	9.93e-05	0.0012	CcSEcCtD
Mitotane—Paraesthesia—Conjugated Estrogens—osteoporosis	9.93e-05	0.0012	CcSEcCtD
Mitotane—Gastrointestinal disorder—Zoledronate—osteoporosis	9.91e-05	0.00119	CcSEcCtD
Mitotane—Rash—Calcitriol—osteoporosis	9.9e-05	0.00119	CcSEcCtD
Mitotane—Dermatitis—Calcitriol—osteoporosis	9.89e-05	0.00119	CcSEcCtD
Mitotane—Headache—Calcitriol—osteoporosis	9.84e-05	0.00119	CcSEcCtD
Mitotane—Somnolence—Conjugated Estrogens—osteoporosis	9.83e-05	0.00118	CcSEcCtD
Mitotane—Pain—Zoledronate—osteoporosis	9.82e-05	0.00118	CcSEcCtD
Mitotane—Nausea—Alendronate—osteoporosis	9.79e-05	0.00118	CcSEcCtD
Mitotane—Hypersensitivity—Risedronate—osteoporosis	9.74e-05	0.00117	CcSEcCtD
Mitotane—Vertigo—Estradiol—osteoporosis	9.74e-05	0.00117	CcSEcCtD
Mitotane—Dyspepsia—Conjugated Estrogens—osteoporosis	9.73e-05	0.00117	CcSEcCtD
Mitotane—Asthenia—Ethinyl Estradiol—osteoporosis	9.73e-05	0.00117	CcSEcCtD
Mitotane—Nausea—Raloxifene—osteoporosis	9.62e-05	0.00116	CcSEcCtD
Mitotane—Decreased appetite—Conjugated Estrogens—osteoporosis	9.61e-05	0.00116	CcSEcCtD
Mitotane—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	9.54e-05	0.00115	CcSEcCtD
Mitotane—Nausea—Ibandronate—osteoporosis	9.53e-05	0.00115	CcSEcCtD
Mitotane—Asthenia—Risedronate—osteoporosis	9.49e-05	0.00114	CcSEcCtD
Mitotane—Feeling abnormal—Zoledronate—osteoporosis	9.46e-05	0.00114	CcSEcCtD
Mitotane—Pain—Conjugated Estrogens—osteoporosis	9.45e-05	0.00114	CcSEcCtD
Mitotane—Hypertension—Estradiol—osteoporosis	9.36e-05	0.00113	CcSEcCtD
Mitotane—Nausea—Calcitriol—osteoporosis	9.33e-05	0.00112	CcSEcCtD
Mitotane—Diarrhoea—Ethinyl Estradiol—osteoporosis	9.28e-05	0.00112	CcSEcCtD
Mitotane—Hypersensitivity—Pamidronate—osteoporosis	9.26e-05	0.00112	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	9.16e-05	0.0011	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	9.09e-05	0.00218	CbGpPWpGaD
Mitotane—Body temperature increased—Zoledronate—osteoporosis	9.07e-05	0.00109	CcSEcCtD
Mitotane—Diarrhoea—Risedronate—osteoporosis	9.05e-05	0.00109	CcSEcCtD
Mitotane—Asthenia—Pamidronate—osteoporosis	9.02e-05	0.00109	CcSEcCtD
Mitotane—Dizziness—Ethinyl Estradiol—osteoporosis	8.97e-05	0.00108	CcSEcCtD
Mitotane—Confusional state—Estradiol—osteoporosis	8.92e-05	0.00107	CcSEcCtD
Mitotane—Infection—Estradiol—osteoporosis	8.79e-05	0.00106	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	8.77e-05	0.0021	CbGpPWpGaD
Mitotane—Dizziness—Risedronate—osteoporosis	8.74e-05	0.00105	CcSEcCtD
Mitotane—Body temperature increased—Conjugated Estrogens—osteoporosis	8.74e-05	0.00105	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	8.72e-05	0.00209	CbGpPWpGaD
Mitotane—Shock—Estradiol—osteoporosis	8.7e-05	0.00105	CcSEcCtD
Mitotane—Nervous system disorder—Estradiol—osteoporosis	8.68e-05	0.00105	CcSEcCtD
Mitotane—Vomiting—Ethinyl Estradiol—osteoporosis	8.62e-05	0.00104	CcSEcCtD
Mitotane—Diarrhoea—Pamidronate—osteoporosis	8.6e-05	0.00104	CcSEcCtD
Mitotane—Skin disorder—Estradiol—osteoporosis	8.59e-05	0.00104	CcSEcCtD
Mitotane—Rash—Ethinyl Estradiol—osteoporosis	8.55e-05	0.00103	CcSEcCtD
Mitotane—Dermatitis—Ethinyl Estradiol—osteoporosis	8.54e-05	0.00103	CcSEcCtD
Mitotane—Headache—Ethinyl Estradiol—osteoporosis	8.49e-05	0.00102	CcSEcCtD
Mitotane—Hypersensitivity—Zoledronate—osteoporosis	8.46e-05	0.00102	CcSEcCtD
Mitotane—CYP11B1—Biological oxidations—POMC—osteoporosis	8.43e-05	0.00202	CbGpPWpGaD
Mitotane—FDX1—Metabolism—ENO1—osteoporosis	8.42e-05	0.00202	CbGpPWpGaD
Mitotane—Vomiting—Risedronate—osteoporosis	8.41e-05	0.00101	CcSEcCtD
Mitotane—Rash—Risedronate—osteoporosis	8.34e-05	0.001	CcSEcCtD
Mitotane—Dermatitis—Risedronate—osteoporosis	8.33e-05	0.001	CcSEcCtD
Mitotane—Dizziness—Pamidronate—osteoporosis	8.31e-05	0.001	CcSEcCtD
Mitotane—FDX1—Metabolism—PSMA5—osteoporosis	8.3e-05	0.00199	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PSMA2—osteoporosis	8.3e-05	0.00199	CbGpPWpGaD
Mitotane—Headache—Risedronate—osteoporosis	8.28e-05	0.000998	CcSEcCtD
Mitotane—Asthenia—Zoledronate—osteoporosis	8.24e-05	0.000992	CcSEcCtD
Mitotane—Hypersensitivity—Conjugated Estrogens—osteoporosis	8.14e-05	0.000981	CcSEcCtD
Mitotane—Nausea—Ethinyl Estradiol—osteoporosis	8.05e-05	0.00097	CcSEcCtD
Mitotane—CYP11B1—Corticotropin-releasing hormone—TGFB1—osteoporosis	8.02e-05	0.00192	CbGpPWpGaD
Mitotane—Vomiting—Pamidronate—osteoporosis	7.99e-05	0.000963	CcSEcCtD
Mitotane—CYP11B1—Metabolism—FDPS—osteoporosis	7.95e-05	0.00191	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PKM—osteoporosis	7.95e-05	0.00191	CbGpPWpGaD
Mitotane—Paraesthesia—Estradiol—osteoporosis	7.94e-05	0.000957	CcSEcCtD
Mitotane—Asthenia—Conjugated Estrogens—osteoporosis	7.93e-05	0.000956	CcSEcCtD
Mitotane—Rash—Pamidronate—osteoporosis	7.92e-05	0.000955	CcSEcCtD
Mitotane—Dermatitis—Pamidronate—osteoporosis	7.92e-05	0.000954	CcSEcCtD
Mitotane—Headache—Pamidronate—osteoporosis	7.87e-05	0.000949	CcSEcCtD
Mitotane—Somnolence—Estradiol—osteoporosis	7.86e-05	0.000948	CcSEcCtD
Mitotane—Diarrhoea—Zoledronate—osteoporosis	7.85e-05	0.000946	CcSEcCtD
Mitotane—Nausea—Risedronate—osteoporosis	7.85e-05	0.000946	CcSEcCtD
Mitotane—Dyspepsia—Estradiol—osteoporosis	7.79e-05	0.000938	CcSEcCtD
Mitotane—Decreased appetite—Estradiol—osteoporosis	7.69e-05	0.000927	CcSEcCtD
Mitotane—Gastrointestinal disorder—Estradiol—osteoporosis	7.64e-05	0.00092	CcSEcCtD
Mitotane—Dizziness—Zoledronate—osteoporosis	7.59e-05	0.000915	CcSEcCtD
Mitotane—Pain—Estradiol—osteoporosis	7.56e-05	0.000912	CcSEcCtD
Mitotane—Diarrhoea—Conjugated Estrogens—osteoporosis	7.56e-05	0.000911	CcSEcCtD
Mitotane—CYP11B1—Metabolism—PGLS—osteoporosis	7.54e-05	0.00181	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GPD2—osteoporosis	7.54e-05	0.00181	CbGpPWpGaD
Mitotane—Nausea—Pamidronate—osteoporosis	7.46e-05	0.000899	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	7.46e-05	0.00179	CbGpPWpGaD
Mitotane—Dizziness—Conjugated Estrogens—osteoporosis	7.31e-05	0.000881	CcSEcCtD
Mitotane—Vomiting—Zoledronate—osteoporosis	7.3e-05	0.000879	CcSEcCtD
Mitotane—Feeling abnormal—Estradiol—osteoporosis	7.29e-05	0.000878	CcSEcCtD
Mitotane—Rash—Zoledronate—osteoporosis	7.24e-05	0.000872	CcSEcCtD
Mitotane—Dermatitis—Zoledronate—osteoporosis	7.23e-05	0.000871	CcSEcCtD
Mitotane—CYP11A1—Biological oxidations—POMC—osteoporosis	7.21e-05	0.00173	CbGpPWpGaD
Mitotane—Headache—Zoledronate—osteoporosis	7.19e-05	0.000867	CcSEcCtD
Mitotane—Vomiting—Conjugated Estrogens—osteoporosis	7.03e-05	0.000847	CcSEcCtD
Mitotane—Body temperature increased—Estradiol—osteoporosis	6.99e-05	0.000843	CcSEcCtD
Mitotane—Rash—Conjugated Estrogens—osteoporosis	6.97e-05	0.00084	CcSEcCtD
Mitotane—Dermatitis—Conjugated Estrogens—osteoporosis	6.96e-05	0.000839	CcSEcCtD
Mitotane—Headache—Conjugated Estrogens—osteoporosis	6.92e-05	0.000834	CcSEcCtD
Mitotane—CYP11B1—Metabolism—ATIC—osteoporosis	6.89e-05	0.00165	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PNP—osteoporosis	6.89e-05	0.00165	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—TGFB1—osteoporosis	6.86e-05	0.00165	CbGpPWpGaD
Mitotane—Nausea—Zoledronate—osteoporosis	6.82e-05	0.000822	CcSEcCtD
Mitotane—CYP11A1—Metabolism—PKM—osteoporosis	6.8e-05	0.00163	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—FDPS—osteoporosis	6.8e-05	0.00163	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CYP19A1—osteoporosis	6.73e-05	0.00162	CbGpPWpGaD
Mitotane—Nausea—Conjugated Estrogens—osteoporosis	6.57e-05	0.000791	CcSEcCtD
Mitotane—Hypersensitivity—Estradiol—osteoporosis	6.52e-05	0.000785	CcSEcCtD
Mitotane—CYP11A1—Metabolism—PGLS—osteoporosis	6.45e-05	0.00155	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GPD2—osteoporosis	6.45e-05	0.00155	CbGpPWpGaD
Mitotane—Asthenia—Estradiol—osteoporosis	6.35e-05	0.000765	CcSEcCtD
Mitotane—Diarrhoea—Estradiol—osteoporosis	6.05e-05	0.000729	CcSEcCtD
Mitotane—CYP11A1—Metabolism—ATIC—osteoporosis	5.9e-05	0.00141	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PNP—osteoporosis	5.9e-05	0.00141	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—OXCT1—osteoporosis	5.86e-05	0.00141	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CA2—osteoporosis	5.86e-05	0.00141	CbGpPWpGaD
Mitotane—Dizziness—Estradiol—osteoporosis	5.85e-05	0.000705	CcSEcCtD
Mitotane—CYP11B1—Metabolism—MGLL—osteoporosis	5.71e-05	0.00137	CbGpPWpGaD
Mitotane—Vomiting—Estradiol—osteoporosis	5.62e-05	0.000678	CcSEcCtD
Mitotane—Rash—Estradiol—osteoporosis	5.58e-05	0.000672	CcSEcCtD
Mitotane—Dermatitis—Estradiol—osteoporosis	5.57e-05	0.000671	CcSEcCtD
Mitotane—Headache—Estradiol—osteoporosis	5.54e-05	0.000668	CcSEcCtD
Mitotane—FDX1—Metabolism—ADCY5—osteoporosis	5.5e-05	0.00132	CbGpPWpGaD
Mitotane—FDX1—Metabolism—GPX1—osteoporosis	5.48e-05	0.00132	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	5.39e-05	0.00129	CbGpPWpGaD
Mitotane—Nausea—Estradiol—osteoporosis	5.25e-05	0.000633	CcSEcCtD
Mitotane—FDX1—Metabolism—MTHFR—osteoporosis	5.06e-05	0.00121	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CA2—osteoporosis	5.01e-05	0.0012	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—OXCT1—osteoporosis	5.01e-05	0.0012	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—MGLL—osteoporosis	4.89e-05	0.00117	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—IDH2—osteoporosis	4.86e-05	0.00116	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	4.61e-05	0.00111	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CYP27A1—osteoporosis	4.57e-05	0.0011	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ACP5—osteoporosis	4.44e-05	0.00107	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.39e-05	0.00105	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—IDH2—osteoporosis	4.15e-05	0.000997	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—TPI1—osteoporosis	4.13e-05	0.000991	CbGpPWpGaD
Mitotane—FDX1—Metabolism—POMC—osteoporosis	4.05e-05	0.000971	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CYP27A1—osteoporosis	3.91e-05	0.000937	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—P4HB—osteoporosis	3.88e-05	0.000931	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GAPDH—osteoporosis	3.81e-05	0.000914	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ACP5—osteoporosis	3.8e-05	0.000912	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.75e-05	0.0009	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—RAP1A—osteoporosis	3.71e-05	0.00089	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—TPI1—osteoporosis	3.53e-05	0.000847	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—P4HB—osteoporosis	3.32e-05	0.000797	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GAPDH—osteoporosis	3.26e-05	0.000782	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.24e-05	0.000776	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—RAP1A—osteoporosis	3.18e-05	0.000762	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ENO1—osteoporosis	3e-05	0.00072	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PSMA2—osteoporosis	2.96e-05	0.000709	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PSMA5—osteoporosis	2.96e-05	0.000709	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.77e-05	0.000664	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ENO1—osteoporosis	2.57e-05	0.000616	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PSMA5—osteoporosis	2.53e-05	0.000607	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PSMA2—osteoporosis	2.53e-05	0.000607	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CYP19A1—osteoporosis	2.4e-05	0.000575	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CYP19A1—osteoporosis	2.05e-05	0.000492	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ADCY5—osteoporosis	1.96e-05	0.00047	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GPX1—osteoporosis	1.95e-05	0.000469	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—MTHFR—osteoporosis	1.8e-05	0.000432	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ADCY5—osteoporosis	1.68e-05	0.000402	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GPX1—osteoporosis	1.67e-05	0.000401	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—MTHFR—osteoporosis	1.54e-05	0.00037	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—POMC—osteoporosis	1.44e-05	0.000346	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—POMC—osteoporosis	1.23e-05	0.000296	CbGpPWpGaD
